Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (VMS)

Details for Australian Patent Application No. 2005230899 (hide)

Owner Wyeth

Inventors Vu, An Thien; Mahaney, Paige Erin; Cohn, Stephen Todd

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005230899

PCT Pub. Number WO2005/097761

Priority 11/091,291 28.03.05 US; 60/557,831 30.03.04 US; 60/569,861 11.05.04 US

Filing date 29 March 2005

Wipo publication date 20 October 2005

International Classifications

C07D 279/16 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms

C07D 241/42 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 265/36 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/097761 Priority application(s): WO2005/097761

28 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005230900-1-(1H-indol-1-yl)-3-(4-methylpiperazin-1 -yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine (NE) and the serotonine (5-HT) activity and the monoamine reuptake for the treatment of vasomotor symptoms (VMS)

2005230897-Asymmetric hydrogenation process useful for the preparation of cycloalkanoindole derivatives